Published: 2018-12-08

Articles

Therapeutics evolving: Bringing the science of innovative treatments into our everyday world

Third Canadian Therapeutics Congress
Abstract 156 | PDF Downloads 428

CANADIAN TRENDS IN BENZODIAZEPINE & ZOPICLONE USE

Aliya Kassam, Scott B Patten
Abstract 320 | PDF Downloads 120

ANTI-DIABETIC DRUG USE AND THE RISK OF MOTOR VEHICLE CRASH IN THE ELDERLY

Brenda Hemmelgarn, Linda E Lévesque, Samy Suissa
Abstract 383 | PDF Downloads 142

CAN CONTRAINDICATIONS COMPROMISE EVIDENCE-BASED, PATIENT- CENTERED CLINICAL PRACTICE?

Victor M Montori, Teresa W Leung, Teresa W Leung, PJ Devereaux, Holger J Schünemann, Elie A Akl, Amiram Gafni, Gordon H Guyatt
Abstract 320 | PDF Downloads 132

FUROSEMIDE USE AND HOSPITALIZATION FOR BENIGN PROSTATIC HYPERPLASIA

JAC Delaney, LE Lévesque, M Etminan, S Suissa
Abstract 865 | PDF Downloads 340

PERSISTENT TARDIVE REBOUND PANIC DISORDER, REBOUND ANXIETY AND INSOMNIA FOLLOWING PAROXETINE WITHDRAWAL: A REVIEW OF REBOUND-WITHDRAWAL PHENOMENA

Nadeem H Bhanji, Guy Chouinard, Theodore Kolivakis, Howard C Margolese
Abstract 686 | PDF Downloads 407

A RANDOMIZED, CONTROLLED, EFFECTIVENESS TRIAL OF OROS- METHYLPHENIDATE COMPARED TO USUAL CARE WITH IMMEDIATE-RELEASE METHYLPHENIDATE IN ATTENTION DEFICIT- HYPERACTIVITY DISORDER

Margaret Steele Steele, Margaret Weiss Weiss, James Swanson Swanson, Jenny Wang, Rosanna S Prinzo, Carin E Binder
Abstract 723 | PDF Downloads 400

DRUG INNOVATION AND PATIENT SAFETY THE NEED FOR A NEW PARADIGM

Canadian Journal of Clinical Pharmacolog
Abstract 171 | PDF Downloads 99

MEDICAL INNOVATION, UNMET MEDICAL NEED, AND THE DRUG PIPELINE

Charles M Mather
Abstract 250 | PDF Downloads 148

Third Canadian Therapeutics Congress

Canadian Journal of Clinical Pharmacolog
Abstract 881 | PDF Downloads 347